| | | | |
CUSIP No. G6829J107 | | Schedule 13G | | Page 10 of 15 |
ITEM 1. | (a) Name of Issuer: |
Ortho Clinical Diagnostics Holdings plc (the “Issuer”).
| (b) Address of Issuer’s Principal Executive Offices: |
1001 Route 202 Raritan, New Jersey 08869
ITEM 2. | (a) Name of Person Filing: |
Each of the following is hereinafter individually referred to as a “Reporting Person” and collectively as the “Reporting Persons.” This statement is filed on behalf of:
The Carlyle Group Inc.
Carlyle Holdings II GP L.L.C.
Carlyle Holdings II L.L.C.
CG Subsidiary Holdings L.L.C.
TC Group Cayman Investment Holdings, L.P.
TC Group Cayman Investment Holdings Sub L.P.
TC Group VI Cayman, L.L.C.
TC Group VI Cayman, L.P.
Carlyle Partners VI Cayman Holdings, L.P.
| (b) Address or Principal Business Office: |
The principal business address of each of TC Group Cayman Investment Holdings, L.P., TC Group Cayman Investment Holdings Sub L.P., TC Group VI Cayman, L.P. and Carlyle Partners VI Cayman Holdings, L.P. is c/o Walkers, 190 Elgin Avenue, George Town, Grand Cayman KY1-9001. The principal business address of each of each of the other reporting persons is c/o The Carlyle Group, 1001 Pennsylvania Ave., NW, Suite 220, Washington, DC 20004-2505.
| (c) Citizenship of each Reporting Person is: |
Each of TC Group Cayman Investment Holdings, L.P., TC Group Cayman Investment Holdings Sub L.P., TC Group VI Cayman, L.P. and Carlyle Partners VI Cayman Holdings, L.P. is organized under the laws of the Cayman Islands. Each of the other Reporting Persons is organized under the laws of the State of Delaware.
| (d) Title of Class of Securities: |
Ordinary shares, $0.00001 par value (“Ordinary Shares”).